31.08.2013 Views

Experimental infection and protection against ... - TI Pharma

Experimental infection and protection against ... - TI Pharma

Experimental infection and protection against ... - TI Pharma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

176 Chapter 9<br />

Figure 1. Study design <strong>and</strong> enrolment<br />

Immunological assessment was performed 1 day before the first immunization<br />

(day I-1) <strong>and</strong> 1 day before the challenge <strong>infection</strong> (day C-1).A final challenge<br />

with infectious mosquito bites was performed 28 days after the<br />

discontinuation of chloroquine prophylaxis.<br />

Methods<br />

Volunteers<br />

Fifteen healthy volunteers were recruited, aged 18-45 years old, without history<br />

of malaria or of residence in a malaria endemic area in the six months prior to<br />

the trial onset. Only one volunteer had ever been in an endemic area, several<br />

years earlier. All volunteers underwent routine physical examination,<br />

haematology <strong>and</strong> biochemistry screening at the Clinical Research Centre<br />

Nijmegen. Serology for HIV, hepatitis B <strong>and</strong> C <strong>and</strong> asexual P. falciparum parasites<br />

was negative in all volunteers. All volunteers gave written informed consent<br />

prior to inclusion. The trial was approved by the Institutional Review Board of

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!